Absci reports second quarter 2021 financial and operating results

Vancouver, wash., sept. 07, 2021 (globe newswire) -- absci corporation (nasdaq: absi), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins, today reported financial and operating results for the quarter ended june 30, 2021.
ABSI Ratings Summary
ABSI Quant Ranking